This document aims to provide guidance for public health and laboratory experts in identifying human infections with animal influenza viruses as early as possible to provide early warning and inform risk assessments and public health measures.
The Protocol is targeted at the national public health reference laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.
This document provides laboratories with a single protocol for producing recombinant full-length hamster prion protein and using it to perform the Real-Time Quaking-Induced Conversion assay (RT-QuIC), which can distinguish sporadic Creutzfeldt-Jakob disease (sCJD) from variant Creutzfeldt-Jakob disease (vCJD).
In collaboration with WHO Regional Office for Europe, ECDC monitors and reports on influenza activity in Europe on a weekly basis throughout the flu season.
In collaboration with WHO Regional Office for Europe, ECDC monitors and reports on influenza activity in Europe on a weekly basis throughout the flu season.
In collaboration with WHO Regional Office for Europe, ECDC monitors and reports on influenza activity in Europe on a weekly basis throughout the flu season.
In collaboration with WHO Regional Office for Europe, ECDC monitors and reports on influenza activity in Europe on a weekly basis throughout the flu season.
In collaboration with WHO Regional Office for Europe, ECDC monitors and reports on influenza activity in Europe on a weekly basis throughout the flu season.